Global Non-invasive Prenatal Testing Market 2017-2021

非侵襲的出生前検査(NIPT)の世界市場2017-2021

◆タイトル:Global Non-invasive Prenatal Testing Market 2017-2021
◆商品コード:IRTNTR15498
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年11月2日
◆ページ数:86
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
Five User(~5名様閲覧用)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、非侵襲的出生前検査(NIPT)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、非侵襲的出生前検査(NIPT)の世界市場規模及び予測、用途別分析、需要先別分析、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は非侵襲的出生前検査(NIPT)の世界市場が2017-2021年期間中に年平均16.86%成長すると予測しています。当レポート上に記載されている主な企業は、BGI Genomics、Illumina、Laboratory Corporation of America Holdings、Quest Diagnostics等です。

About Non-invasive Prenatal Testing
Non-invasive prenatal screening is performed primarily by ultrasonography and serum testing from maternal plasma. Ultrasonography uses the clear tissue behind the infant’s neck to detect genetic defects. A fetus with abnormalities tends to accumulate more fluid. Hence, more clear space is detected behind the neck, which is an indicative measure. Maternal serum screening is a method that involves blood testing in the first and second trimester of the gestation period where specific chemicals such as pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (HCG) are checked.

Technavio’s analysts forecast the global non-invasive prenatal testing market to grow at a CAGR of 16.86% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Non-invasive Prenatal Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BGI Genomics
• Illumina
• Laboratory Corporation of America Holdings
• Quest Diagnostics

[Other prominent vendors]
• Agilent Technologies
• Berry Genomics
• F. Hoffman-La Roche
• LifeCodexx
• Natera
• PerkinElmer

[Market driver]
• Advantages of non-invasive methods over invasive methods
• For a full, detailed list, view our report

[Market challenge]
• Abortion rate and ethical hurdles
• For a full, detailed list, view our report

[Market trend]
• Increase in acceptance of NIPT
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Overview

PART 05: MARKET LANDSCAPE
• Overview
• Market size and forecast
• Five forces analysis

PART 06: SEGMENTATION BY APPLICATION
• Overview
• Trisomy
• Microdeletions
• Others

PART 07: SEGMENTATION BY END-USER
• Overview
• Diagnostic centers
• Hospitals

PART 08: SEGMENTATION BY GEOGRAPHY
• Overview
• Regional comparison
• NIPT market in Americas
• NIPT market in EMEA
• NIPT market in APAC
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 11: MARKET TRENDS
• Increase in acceptance of NIPT
• Increase in genetic counseling
• Growth of genetic screening programs at births

PART 12: VENDOR LANDSCAPE
• Competitive scenario
• Investment opportunities

PART 13: KEY VENDOR ANALYSIS
• BGI Genomics
• Illumina
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Other prominent vendors

PART 14: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Types of prenatal diagnosis and screening
Exhibit 02: Lifecycle of prenatal testing techniques
Exhibit 03: Comparative analysis of NIPT with other techniques
Exhibit 04: Global NIPT market: Overview 2017-2021
Exhibit 05: Global NIPT market 2016-2021 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Global NIPT market: Segmentation by application 2016 (% share)
Exhibit 08: Global NIPT market: Segmentation by application 2021 (% share)
Exhibit 09: Global NIPT market: Segmentation by application 2016-2021 (% share)
Exhibit 10: Global NIPT by trisomy market 2016-2021 ($ millions)
Exhibit 11: Global NIPT by microdeletions market 2016-2021 ($ millions)
Exhibit 12: Global NIPT by others market 2016-2021 ($ millions)
Exhibit 13: Global NIPT market: Segmentation by end-user 2016-2021 (% share)
Exhibit 14: Global NIPT market by diagnostic centers 2016-2021 ($ millions)
Exhibit 15: Global NIPT market by hospitals 2016-2021 ($ millions)
Exhibit 16: Global NIPT market: Segmentation by geography 2016-2021 (% share)
Exhibit 17: Global NIPT market: Regional comparison
Exhibit 18: NIPT market in Americas 2016-2021($ millions)
Exhibit 19: NIPT market in Americas: Year-over-year growth 2017-2021 (%)
Exhibit 20: NIPT market in EMEA 2016-2021 ($ millions)
Exhibit 21: NIPT market in EMEA: Year-over-year growth (%) (2017-2021)
Exhibit 22: NIPT market in APAC 2016-2021 ($ million)
Exhibit 23: NIPT market in APAC: Year-over-year growth 2017-2021 (%)
Exhibit 24: Global NIPT market: Key leading countries
Exhibit 25: Global NIPT market: Growth and success factors of vendors
Exhibit 26: Global NIPT market: Investment opportunity mapping
Exhibit 27: BGI Genomics: Overview
Exhibit 28: BGI Genomics: Strength analysis
Exhibit 29: BGI Genomics: Strategy assessment
Exhibit 30: BGI Genomics opportunity assessment
Exhibit 31: Illumina: Overview
Exhibit 32: Illumina: Strength analysis
Exhibit 33: Illumina: Strategy assessment
Exhibit 34: Illumina: Opportunity assessment
Exhibit 35: Laboratory Corporation of America Holdings: Overview
Exhibit 36: Laboratory Corporation of America Holdings: Strength analysis
Exhibit 37: Laboratory Corporation of America Holdings: Strategy assessment
Exhibit 38: Laboratory Corporation of America Holdings: Opportunity assessment
Exhibit 39: Quest Diagnostics Overview
Exhibit 40: Quest Diagnostics: Strength analysis
Exhibit 41: Quest Diagnostics: Strategy assessment
Exhibit 42: Quest Diagnostics: Opportunity assessment



【掲載企業】

BGI Genomics, Illumina, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies, Berry Genomics, F. Hoffman-La Roche, LifeCodexx, Natera, and PerkinElmer.


【資料のキーワード】

非侵襲的出生前検査(NIPT)、新型出生前診断、母体血胎児染色体検査

★調査レポート[非侵襲的出生前検査(NIPT)の世界市場2017-2021] (Global Non-invasive Prenatal Testing Market 2017-2021 / IRTNTR15498)販売に関する免責事項
[非侵襲的出生前検査(NIPT)の世界市場2017-2021] (Global Non-invasive Prenatal Testing Market 2017-2021 / IRTNTR15498)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆